A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/38 (2006.01) A61K 9/00 (2006.01) A61K 9/06 (2006.01)
Patent
CA 2172373
Drug delivery vehicles which reversibly increase in either loss modulus or storage modulus, or both, upon contact with the eye, skin, mucous membrane or body cavity are disclosed. The vehicles contain one or more nonionic substituted cellulose ethers and do not require a charged sufactant or a pH-sensitive polymer for such increase in loss modulus or storage modulus, or both, upon administration. In one embodiment, the vehicles gel upon instillation in the eye.
L'invention concerne des excipients présentant une augmentation réversible du module de perte ou du module de conservation, ou des deux, lors du contact avec l'oeil, la peau, les muqueuses ou les cavités du corps. Ces excipients contiennent un ou plusieurs éthers cellulosiques substitués non ioniques et ne nécessitent pas un tensioactif chargé ou un polymère sensible au pH pour une telle augmentation du module de perte ou du module de conservation, ou des deux lors de l'administration. Dans un mode de réalisation, ces excipients se gélifient lors de l'instillation dans l'oeil.
Kabra Bhagwati P.
Lang John C.
Alcon Laboratories Inc.
Smart & Biggar
LandOfFree
Thermally-gelling ophthalmic drug delivery vehicles... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thermally-gelling ophthalmic drug delivery vehicles..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thermally-gelling ophthalmic drug delivery vehicles... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1570830